All Stories

  1. In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles

    Article • International Journal of Nanomedicine, June 2014, Taylor & Francis

    Mr Marc Masa

  2. S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

    Article • Oncogenesis, March 2014, Springer Science + Business Media

    Mr Marc Masa

  3. Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody

    Article • PLOS One, September 2013, PLOS

    Mr Marc Masa

  4. 1058 S100A4 Acts Synergistically With VEGF in Promoting Angiogenesis and a Neutralizing Monoclonal Antibody Against S100A4 Could Be a Novel Strategy to Combat Solid Tumors

    Article • European Journal of Cancer, July 2012, Elsevier

    Mr Marc Masa

  5. 1053 New Strategies to Inhibit Tumor Cell Proliferation and Tumor Metastasis by S100P Monoclonal Antibodies

    Article • European Journal of Cancer, July 2012, Elsevier

    Mr Marc Masa